期刊文献+

间质性肺疾病的分子遗传学研究进展 被引量:1

Recent Advancement of Interstitial Lung Disease in Molecular Genetics
暂未订购
导出
摘要 间质性肺疾病是病因、发病机制、病理特征、治疗和预后有所不同,但其临床表现、影像学改变和肺功能损害相似的一组疾病。阐述近年来间质性肺疾病的分子遗传学研究进展,旨在寻找新的可能的治疗靶点。 Interstitial lung disease is a group of lung diseases having their own etiology,pathogenesis, pathological feature, therapy and prognosis, which have similar clinical manifestation, imaging changes and lung functional lesion. This article reviews the study progress of interstitial disease in molecular genetics in order to seek the possible therapeutic target.
出处 《医学综述》 2008年第12期1785-1787,共3页 Medical Recapitulate
关键词 间质性肺疾病 分子遗传学 基因 Interstitial lung disease Molecular genetics Gene
  • 相关文献

参考文献22

  • 1于润江.间质性肺疾病的分类[J].中华结核和呼吸杂志,2002,25(9):516-519. 被引量:21
  • 2Wahidi MM, Speer MC, Steele MP,et al. Familial pulmonary fibrosis in the United States[J]. Chest,2002,121 (3 Suppl) :30S.
  • 3Barth RK, Hanchett LA, Baecher-Allan CM. Mapping susceptibility genes for the induction of pulmonary fibrosis in mice [ J]. Chest, 2002,121 ( 3 Suppl) :21S.
  • 4Molina V, Blank M, Shoenfeld Y, et al. Fibrotic disease [ J ]. Harefuah, 2002,141 ( 11 ) : 973-978.
  • 5Selman M ,Pardo A. Idiopathic pulmonary fibrosis : an epithelial/fibroblastic cross-talk disorder[ J]. Respir Res,2002,3 ( 1 ) :3.
  • 6Strieter RM. Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis[ J]. Am J Respir Crit Care Med,2002,165(9) :1206-1207.
  • 7Awad MR, EI-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-betal gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation [ J ]. Transplantation, 1998, 66(8) : 1014-1020.
  • 8郑悦,康健,侯显明.用RT-PCR方法动态分析博莱霉素致肺纤维化大鼠TGF-β_1的基因表达[J].中国医科大学学报,2001,30(2):94-95. 被引量:8
  • 9叶旭军,徐启勇,叶燕青.结缔组织生长因子基因表达与肺纤维化关系初探[J].武汉大学学报(医学版),2004,25(5):521-523. 被引量:5
  • 10Kothapalli D, Grotendorst GR. CTGF modulates cell cycleprogression in cAMP. Arrested NRK fibroblasts [ J ]. J Cell Physiol,2000, 182( 1 ) :119-126.

二级参考文献26

  • 1Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin inducedinterstitialpulmonary diseasesin then ude,athymicomouse. AmRvRespDis,1979,120:893
  • 2Weston BS, Wahab NA, Mason RM. CTGF mediates TGF-beta_induced fibronectin matrix deposition by upreglating active alpha5betal integrin in human mesangial cells. Journal of American Society of Nephrology,2003,14(3) :601
  • 3Holmes A, Abraham DJ, Susan S, et al. CTGT and SMADs,Mainte nanceof Scleroderma PhenotypeIsIdependentofs MAD Signaling. J Biol Chem, 2001,276 (14): 10594
  • 4Ingrid E Blom,Roel Goldschmeding,Andrew Leask. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biology, 2002,21: 473
  • 5Kothapalli D, Grotendorst GR. CTGF modulates cell cycleprogression in cAMP. arrested NRK fibroblasts. J Cell Physiol,2000,182(1) :119
  • 6Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol, 2001, 99:308 -319.
  • 7Lukacs NW, Hogaboam C, Chensue SW, et al. Type l/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest,2001, 120(1 Suppl) : 5S-8S.
  • 8Maeyama T, Kuwano K, Kawasaki M, et al. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am J Physiol Lung Cell Mol Physiol, 2001, 280:1128-1137.
  • 9Jaffe HA, Gao ZC, Moil Y, et al. Selective inhibition of collagen gene expression in fibroblasts by an interferon-3, transgene. Exp Lung Res, 1999, 25: 199-215.
  • 10Ziesche R, Hotbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1 b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med, 1999, 341 : 1264-1269.

共引文献51

同被引文献15

  • 1牟晓燕,林殿杰,辛洪涛.肺间质纤维化的分子生物学发病机制及治疗新进展[J].国际呼吸杂志,2006,26(12):928-931. 被引量:17
  • 2党军,周朝晖,缪宏宇.兔放射性肺纤维化形成过程中一氧化氮含量变化及诱导型一氧化氮合成酶的表达[J].中国医科大学学报,2007,36(2):148-149. 被引量:6
  • 3Strieter RM, Gomperts BN, Keahe MP, et al. The role of CXC chemokines in pulmonary fibrosis [J]. J Clin Invest, 2007, 117 ( 3 ) : 549-556.
  • 4Smith MR, Gangireddy SR. Narala VR, et al. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following ble- ommycin-induced lung injury [ J ]. Am J Physiol Lung Cell Mol Physiol, 2010, 298 (5): 616-625.
  • 5Bernstein HS, Srivastava D. Stem-cell therapy for cardiac disease [J]. Pediatr Res, 2012, 71 (2): 491-499.
  • 6Forbes SJ. Stem cell therapy for chronic liver disease-choosing the right tools for the job [J]. Gut, 2008, 57 (2) : 153-155.
  • 7Ullah K, Ahmed P, Raza S, et al. Allogeneic stem cell transplan- tation in hematological disorders: single center experience from Parkistan [J]. Transplant Proc, 2007, 39 (10): 3347-3357.
  • 8Kotton DN, Ma BY, Cardoso WV, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium [ J ]. Development, 2001, 128 (24): 5181-5188.
  • 9Waiters DM, Cho HY, Kleeberger SR. Oxidative stress and an- tioxidants in the pathogenesis fibrosis a potenital role for Nrf2 [ J ]. Antioxid Redox Signal, 2008, 10 (2) : 321-332.
  • 10Liu H, Zhang H, Forman H J, Silica induces macrophage cyto- kines through phosphatidylcholine-specific phospholipase C with hy- dogen peroxide [ J ]. Am J Respir Cell Mol Biol, 2007, 36 (5) : 594 -599.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部